Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism.
Autism brains are short on serotonin receptors in social-emotion hubs, giving future meds a clear bull’s-eye.
01Research in Context
What this study did
Oblak et al. (2013) looked at thin slices of donated brain tissue. They compared people with autism to people without it.
They counted two kinds of serotonin docking stations—5-HT1A and 5-HT2A—in the posterior cingulate and the fusiform gyrus. These areas help us read faces and feelings.
What they found
The autism group had fewer serotonin receptors in both regions. The transporter that recycles serotonin was also lower.
Fewer receptors mean weaker serotonin signals. That could dull social learning circuits.
How this fits with other research
Tarchi et al. (2026) scanned living autistic brains. They saw thinner cortex exactly where Adrian found missing receptors. The thinner the spot, the worse the child’s social scores. Together they point to the same drug target.
Martens et al. (1989) drew blood, not brains. They found extra serotonin in the bloodstream. Adrian shows less serotonin hardware inside the brain. High blood levels and low brain locks look opposite, but both can stall serotonin balance.
Matson et al. (2011) studied the same donated patches. They saw scrambled cell layers yet normal cell counts. Adrian adds the chemical layer: even if cells stay, their serotonin antennas are gone.
Why it matters
You can’t count receptors in session, but you can watch social motivation. If a client seems flat to faces or voices, pair that cue with your reinforcement plan. Future meds may aim at these receptors; your data on social response could help doctors judge if those drugs work.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Track how fast your client orients to faces during social tasks—note any flat response as possible soft sign to share with the medical team.
02At a glance
03Original abstract
Autism is a behaviorally defined, neurological disorder with symptom onset before the age of 3. Abnormalities in social-emotional behaviors are a core deficit in autism, and are characterized by impaired reciprocal-social interaction, lack of facial expressions, and the inability to recognize familiar faces. The posterior cingulate cortex (PCC) and fusiform gyrus (FG) are two regions within an extensive limbic-cortical network that contribute to social-emotional behaviors. Evidence indicates that changes in brains of individuals with autism begin prenatally. Serotonin (5-HT) is one of the earliest expressed neurotransmitters, and plays an important role in synaptogenesis, neurite outgrowth, and neuronal migration. Abnormalities in 5-HT systems have been implicated in several psychiatric disorders, including autism, as evidenced by immunology, imaging, genetics, pharmacotherapy, and neuropathology. Although information is known regarding peripheral 5-HT in autism, there is emerging evidence that 5-HT systems in the central nervous system, including various 5-HT receptor subtypes and transporters, are affected in autism. The present study demonstrated significant reductions in 5-HT1A receptor-binding density in superficial and deep layers of the PCC and FG, and in the density of 5-HT(2A) receptors in superficial layers of the PCC and FG. A significant reduction in the density of serotonin transporters (5-HTT) was also found in the deep layers of the FG, but normal levels were demonstrated in both layers of the PCC and superficial layers of the FG. This study provides potential substrates for decreased 5-HT modulation/innervation in the autism brain, and implicate two 5-HT receptor subtypes as potential neuromarkers for novel or existing pharmacotherapies.
Autism research : official journal of the International Society for Autism Research, 2013 · doi:10.1002/14651858.CD009043.pub2